Where does Owl biomedical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Owl biomedical, Inc. ranks #14,840 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Owl biomedical, Inc. hold?

Owl biomedical, Inc. holds 20 US utility patents granted between 2015 and 2024, spanning 8 technology areas.

What is Owl biomedical, Inc.'s Innovation Score?

Owl biomedical, Inc. has an Innovation Score of 36.8 out of 100 (top 45% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Owl biomedical, Inc. focus on?

Owl biomedical, Inc.'s top technology area is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE) with 19 patents, ranking #96 of 1,325 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Owl biomedical, Inc.'s patent grant rate increasing or decreasing?

Owl biomedical, Inc.'s recent grant velocity is -67% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Owl biomedical, Inc.'s patents?

Owl biomedical, Inc.'s patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Owl biomedical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Owl biomedical, Inc.

USPTO PatentsView assignee record - 20 granted patents across 8 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Owl ranks #14,840 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 8 technology areas.

#14,840
of 49,997 US assignees by volume: Top 45%
by Innovation Score (36.8/100): 18.8
avg claims per patent: -67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14840 · US Corporation #14,840 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,840/49,997
PHOTO-FINISH Optovate
CPC-NARROW B01L · 8 areas
INNOV-THIN 36.8/100
CLAIMS-RICH 18.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Optovate Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Owl’s 36.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (29%) Velocity 5.0 pts (14%) Breadth 10.0 pts (27%) Claim depth 11.3 pts (31%)

Qualcomm Incorporated · highest

85
Owl biomedical · this assignee

37
3D Lighting… · lowest

7

What this shows Owl's Innovation Score is 36.8/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Owl?

Each dot is one of Owl’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Owl’s own 18.8 claims/patent is ABOVE the 15.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Owl vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Owl's grants concentrate

Owl biomedical, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 95% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2016 (6 grants) versus a trough of 1 in 2017. By volume, Owl sits between Optovate Limited and Paris Sciences ET Lettres - Quartier Latin.

Owl's three-year grant acceleration

Owl biomedical, Inc. shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Optovate

20
Ostomycure AS

20
Otonexus Medical

20
Otsuka Medical De…

20
Paion UK

20
Palfinger

20
PAN Pacific Plast…

20
Paris Sciences ET…

20
Owl biomedical ◀

20

What this shows Owl holds 20 patents at rank #14,836, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Owl

By rank, the assignees closest to #14,836 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Owl's primary technology class.

Owl's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Owl biomedical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	10.0%
2016	6	30.0%
2017	1	5.0%
2018	4	20.0%
2019	2	10.0%
2020	1	5.0%
2021	1	5.0%
2023	1	5.0%
2024	2	10.0%

Which technologies does Owl biomedical, Inc. patent most?

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 19

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 18

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; Devices FOR Venting OR Aerating 8

B07C - Postal SORTING; Sorting Individual Articles, OR Bulk Material FIT TO BE Sorted Piece-meal, e.g. BY Picking 5

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 3

B81B - Microstructural Devices OR Systems, e.g. Micromechanical Devices 1

Y10T - Technical Subjects Covered BY Former US Classification 1

F17D - Pipe-line SYSTEMS; Pipe-lines 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Owl biomedical, Inc.'s patent record in context - here's where to go next.

Owl biomedical, Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 95% of its portfolio - see every assignee active in that class. Explore B01L
Ranked #14,840 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Owl biomedical, Inc. against Optovate Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.